The simulation results presented here demonstrate the potential of the adaptive CRT device with dynamic optimization of AV and VV intervals for improving cardiac output beyond the current non-adaptive ...

Dr. Hunter Champion answers the question: 'What Is A Biventricular Pacemaker?' — -- Question: What is a biventricular pacemaker or cardiac resynchronization therapy (also called a CRT device), ...

Multiple societies covering cardiovascular medicine, electrophysiology, heart failure, and imaging have released updated appropriate use criteria (AUC) for various cardiac implantable electronic ...

Indianapolis, IN - A European postmarketing surveillance study of Guidant Corporation's cardiac resynchronization device for use in heart failure (HF) has shown that 60% of the 1000 patients using it ...

The heart is a finely tuned machine, pumping and squeezing to move blood through the body with a fresh supply of oxygen and nutrients. Electrical activity provides the spark to coordinate and activate ...

-- EUR35 million Series C funding to accelerate the clinical and industrial development of FlowMaker (R) -- EUR48 million in grants from the IPCEI Tech4Cure program to structure the European Active ...

Please provide your email address to receive an email when new articles are posted on . A universal remote monitoring platform was associated with lower mortality and fewer hospitalizations than ...

Please provide your email address to receive an email when new articles are posted on . Major adverse events remained common in patients with nonischemic cardiomyopathy implanted with an electronic ...

MINNEAPOLIS -- The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D ...

Medtronic is recalling nearly 350,000 implantable cardiac devices due to continued problems with the delivery of high-voltage energy, according to an announcement from the US Food and Drug ...

Series C funding to accelerate the clinical and industrial development of FlowMaker®€48 million in grants from the IPCEI Tech4Cure program to structure the European Active Implantable Medical Devices ...